Veillonella As a Bile Acid-Sensitive Bacteria and a Microbiome-Based Biomarker for Aldafermin (NGM282) in Patients with Non-Alcoholic Steatohepatitis

0 100 200 300 400 Rohit Loomba 1, Lei Ling 2, Duy M. Dinh 3, Bryan A. Baxter 2, Alex M. DePaoli 2, Hsiao D. Lieu 2, Stephen A. Harrison 4,5 and Arun Sanyal 6 1University of California, San Diego, United States; 2NGM Biopharmaceuticals, South San Francisco, United States; 3Diversigen, Houston, United States; 4University of Oxford, London, United Kingdom; 5Pinnacle Clinical Research, San Antonio, United States; 6Virginia Commonwealth University, Richmond, United States Veillonella as a Bile Acid-Sensitive Bacteria and a Microbiome-Based Biomarker for Aldafermin (NGM282) in Patients with Non-Alcoholic Steatohepatitis